News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
News
December 17, 2020
America's Best Mid-size Companies
Andrea Murphy, Hank Tucker Forbes
News
November 19, 2020
Repligen CEO Tony Hunt Knows Why Success Takes Time
Marilyn Munch Investor's Business Daily
News
October 28, 2020
Repligen strengthens downstream offering with $200m ARTeSYN acquisition
Dan Stanton BioProcess International
News
October 8, 2020
Navigo and Repligen Team on COVID-19 Vaccine Affinity Resin
Dan Stanton BioProcess International
News
September 1, 2020
Continuous Processing: A Step on the Way to Bioprocess 4.0
Gareth John Macdonald GEN
News
July 1, 2020
Repligen boosting single-use portfolio with Engineered Molding Technology buy
BPI Staff BioProcess International
News
February 14, 2020
Repligen up on OPUS® and Gene Therapy Demand
Dan Stanton BioProcess International
News
October 1, 2019
Using Alternating Tangential Flow with Fed-Batch Cultures
GEN
News
August 12, 2019
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application.
Samsung Biologics
News
August 12, 2019
Samsung BioLogics’ cell culture technique to cut production life by 30%
Pulse News
News
August 12, 2019
Samsung BioLogics implants cell-culturing tech
Korea Biomed
News
August 12, 2019
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application
Yahoo News